It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2020.
2020 | Ahmedabad, Gujarat, India | ActiveReehel Pharmaceuticals Private Limited, a active private limited company, was established on 12 September 2020 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290GJ2020PTC116465. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Its leadership includes Rekhaben Virenkumar Patel (Director), Viren Ramanlal Patel (Director). Past directors included Pratikkumar Shah, Nareshkumar Rasiklal Patel. It holds ₹1.70 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Godown No: 5423, Harimukt Estate, Near Harsiddhi Estate, Chosar Road, Asal, Ali,, Ahmedabad, Gujarat, 382427.
U24290GJ2020PTC116465
116465
12 September 2020
₹5.00 M
₹5.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Reehel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rekhaben Virenkumar Patel | Director | 12 Sep 2020 | Current |
| Viren Ramanlal Patel | Director | 12 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Sep 2021 | Past |
| Pramod Abcsdd | Director | 18 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Reehel Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 367.79% increase. The company also saw a substantial improvement in profitability, with a 194.59% increase in profit. The company's net worth Soared by an impressive increase of 14.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Reehel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹17,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jan 2021 | Others | ₹1.70 Cr | Open |
Explore comprehensive loan charge details -
Reehel Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Reehel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reehel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Reehel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Progress on Reehel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad. was documented.
A charge with Others of Rs. 17.00 M registered on 06 Jan 2021 with Charge ID 100409204 was modified on 01 Aug 2022. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 17.00 M with Charge ID 100409204 was registered on 06 Jan 2021. was documented.
Progress on Rekhaben Virenkumar Patel was appointed as a Director was appointed as a Director on 12 Sep 2020 & has been associated with this company since 5 years 3 months . was documented.
The activity Viren Ramanlal Patel was appointed as a Director was appointed as a Director on 12 Sep 2020 & has been associated with this company since 5 years 3 months . was completed.
The CIN of Reehel Pharmaceuticals Private Limited is U24290GJ2020PTC116465.
Reehel Pharmaceuticals Private Limited is headquartered at Godown No: 5423, Harimukt Estate, Near Harsiddhi Estate, Chosar Road, Asal, Ali,, Ahmedabad, Gujarat, 382427.
Reehel Pharmaceuticals Private Limited was incorporated on 12 September 2020.
The current directors of Reehel Pharmaceuticals Private Limited are
The primary industry of Reehel Pharmaceuticals Private Limited is Trade.
Reehel Pharmaceuticals Private Limited is unlisted.
The authorized capital of Reehel Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX